Skip to content

ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis

Acute Electrocorticography (ECoG) Direct Brain Interface for Individuals With Upper Limb Paralysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01393444
Enrollment
6
Registered
2011-07-13
Start date
2011-05-31
Completion date
2015-04-30
Last updated
2016-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALS, Brachial Plexus Injury, Brainstem Stroke, Muscular Dystrophy, Spinal Cord Injury, Tetraplegia

Keywords

Electrocorticography, Tetraplegia, Spinal cord injury, Brainstem stroke, Neuroprosthetic, Brain-computer interface, Direct brain interface, Neural activity, Motor cortex

Brief summary

The purpose of this research study is to demonstrate that individuals with upper limb paralysis due to spinal cord injury, brachial plexus injury, amyotrophic lateral sclerosis and brain stem stroke can successfully achieve direct brain control of assistive devices using an electrocorticography (ECoG)-based brain computer interface system.

Detailed description

Brain-computer interface (BCI) technology aims to establish a direct link for transmitting information between the brain and external devices, offering a natural and rich control signal for prosthetic hands or functional electrical stimulators (FES) to re-animate paralyzed hands. This study focuses on an ECoG-based BCI system. ECoG measures brain activity using electrodes implanted on the surface of the brain. Each participant will undergo testing of the ECoG direct brain interface for up to 29 days. Participants will learn to control computer cursors, virtual reality environments, and assistive devices such as hand orthoses and functional electrical stimulators using neural activity recorded with the ECoG sensor.

Interventions

DEVICEImplantation of ECoG sensors on the brain surface

One ECoG sensor will be implanted over the motor cortex of study participants

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Limited or no ability to use both hands due to cervical spinal cord injury, brachial plexus injury, brainstem stroke, muscular dystrophy, or amyotrophic lateral sclerosis (ALS) or other motor neuron diseases * At least 1 year post-injury * Live within 1 hour of the University of Pittsburgh or willing to stay in Pittsburgh while the ECoG electrode is implanted (up to 29 days) * Additional inclusion criteria must also be reviewed

Exclusion criteria

* Certain implanted devices * Presence of other serious disease or disorder that could affect ability to participate in this study * Additional

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Able to Successfully Control of a Variety of External Devices Using Neural Data Recorded With ECoGUp to 29 days of device implantationParticipants will attempt to control devices such as computer cursors, virtual reality environments and assistive devices such as hand orthoses or surface functional electrical stimulators using their brain activity recorded through ECoG.

Secondary

MeasureTime frameDescription
Number of Participants Able to Achieve Direct Brain Control of Assistive Devices Using an Electrocorticography (ECoG)-Based Brain-computer Interface SystemUp to 29 days of device implantationParticipants will be asked to perform, attempt, or imagine performing motor tasks while their brain activity is recorded in order to observe the changes in neural activity during each task.

Countries

United States

Participant flow

Recruitment details

Recruitment included interfacing with local research registry participants, clinical SCI physicians, MDS and ALS groups, and attending conferences attended by eligibility populations

Pre-assignment details

This study did not include arms or group assignments.

Participants by arm

ArmCount
Direct Brain Interface Users
All participants enrolled in the study will undergo Implantation of ECoG sensors on the brain surface to record neural activity. There is no control group. There are no other arms. Implantation of ECoG sensors on the brain surface: One ECoG sensor will be implanted over the motor cortex of study participants
6
Total6

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDetermined ineligible during screening.2
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicDirect Brain Interface Users
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
Age, Continuous39 years
Region of Enrollment
United States
6 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
1 / 6
serious
Total, serious adverse events
0 / 6

Outcome results

Primary

Number of Participants Able to Successfully Control of a Variety of External Devices Using Neural Data Recorded With ECoG

Participants will attempt to control devices such as computer cursors, virtual reality environments and assistive devices such as hand orthoses or surface functional electrical stimulators using their brain activity recorded through ECoG.

Time frame: Up to 29 days of device implantation

Population: Individuals with limited or no ability to use one or both hands due to cervical spinal cord injury, brachial plexus injury, brainstem stroke, muscular dystrophy, cerebral palsy or amyotrophic lateral sclerosis (ALS) or other motor neuron disease.

ArmMeasureValue (NUMBER)
Direct Brain Interface UsersNumber of Participants Able to Successfully Control of a Variety of External Devices Using Neural Data Recorded With ECoG3 participants
Secondary

Number of Participants Able to Achieve Direct Brain Control of Assistive Devices Using an Electrocorticography (ECoG)-Based Brain-computer Interface System

Participants will be asked to perform, attempt, or imagine performing motor tasks while their brain activity is recorded in order to observe the changes in neural activity during each task.

Time frame: Up to 29 days of device implantation

Population: Individuals with limited or no ability to use one or both hands due to cervical spinal cord injury, brachial plexus injury, brainstem stroke, muscular dystrophy, cerebral palsy or amyotrophic lateral sclerosis (ALS) or other motor neuron disease.

ArmMeasureValue (NUMBER)
Direct Brain Interface UsersNumber of Participants Able to Achieve Direct Brain Control of Assistive Devices Using an Electrocorticography (ECoG)-Based Brain-computer Interface System3 participants

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026